Affiliation:
1. Pereira Rossell Children´s Hospital
2. 5Departamento de Salud Pública, Escuela de Medicina.
3. Pontificia Universidad Católica de Chile
Abstract
Abstract
Objective To explore the association between antenatal magnesium sulphate ( MgSO4 ), mortality and incidence of intraventricular hemorrhage (IVH) in very low birth weight (VLBW) infants.Study design Retrospective, cohort study of infants < 32 weeks’ GA born at centers of NEOCOSUR Network between January 2015 and December 2020. Subjects were categorized as exposed vs non-exposed to antenatal MgSO4. Primary outcomes were death, incidence of severe IVH (Grade III-IV) and severe IVH/death. Secondary outcomes included relevant morbidities.Results 7418 VLBW infants were eligible. Antenatal MgSO4 was associated with a significantly decreased death rate after admission (aOR 0.59 [95% CI, 0.46–0.74]) and severe IVH/ death (aOR 0.63 [95% CI, 0.49–0.83]). No significant reduction in severe IVH was observed (aOR 0.89 [95% CI, 0.63–1.25]). No differences between groups were observed in rates of morbidities.Conclusion Antenatal MgSO4 was associated with a decreased death rate after admission and in severe IVH/ death.
Publisher
Research Square Platform LLC
Reference21 articles.
1. Magnesium for neuroprophylaxis: fact or fiction?;Cahill AG;Am J Obstet Gynecol,2009
2. FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection;Shennan A;International Journal of Gynecology and Obstetrics,2021
3. Antenatal magnesium sulphate neuroprotection in the preterm infant;Marret S;Semin Fetal Neonatal Med,2007
4. Antenatal Magnesium and Cerebral Palsy in Preterm Infants;Hirtz DG;Journal of Pediatrics,2015
5. Lw D, Ca C, Middleton P, Rouse MS. Magnesium Sulphate for Women at Risk of Preterm Birth for Neuroprotection of the Fetus (Review).; 2010.